The Fine Chemical Benchmarking Service analyses the fine chemical industry. Within that industry Part 1 focuses on the largest and most important segment: fine chemicals for the pharmaceutical industry. Part 4 focuses on all other fine chemical segments.
The service is provided on an annual subscription basis. It consists of four parts, and a total of more than 1,000 pages. The updating frequency is once a year for Part 1, Part 3 and Part 4; twice a year for Part 2. Typically the data of the previous versions also remain part of the new document, which gives easy access to historic developments of the companies and markets involved. Data goes back to 1999 for Parts 1 and 2, and as far as 1990 for some of the companies in Part 3. The current first edition of Part 4 includes some data going back to 2000 (agrochemicals and agchem intermediates).
Part 1 (The Pharmaceutical Fine Chemical Industry -Current Status and Trends-)
provides an analysis of the current status and dynamics of the pharmaceutical industry from a fine chemical point of view.
The segments in the development phase of the pharmaceutical product life cycle are analysed in terms of:
Total value of each of the segments
Fine chemical value of each of the segments
Cost and success rate of pharmaceutical development
Total pharmaceutical R&D expenditure
R&D expenditure breakdown by type
Chemical versus other expenditure in pharmaceutical R&D